Disclosed are humanized antibodies that bind specifically to TNF superfamily member 15 (TNFSF 15), also known as TLlA. Methods of making and using the anti-TLl A antibodies are also described. The humanized antibodies may be antagonists and may used to treat or diagnose conditions associated with TLlA function.
申请公布号
MX2010005282(A)
申请公布日期
2010.08.31
申请号
MX20100005282
申请日期
2008.11.13
申请人
TEVA PHARMACEUTICALS USA, INC.
发明人
ROSCHKE, VIKTOR;SMITH, RODGER;KANAKARAJ, PALANISAMY;ROSEN, CRAIG;COOKSEY, BRIDGET A.
